A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Cromolyn (Gastrocrom)

Mast Cell Stabilizer class · 8 generic manufacturers · 9 ANDAs filed at FDA.

First FDA approval1999-06-29
Generic availableYes · 8 mfrs
Shortage statusActive shortage
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$15.2M in CY2024 Part D spend145K claims · 69K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.330/unit
9 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.772
Across all dosage forms in distribution.
Highest NADAC
$2.44
Wide spread — brand-strength NDCs still in market.
Plans with PA
329 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Cromolyn used for?

Cromolyn is a Mast Cell Stabilizer medication tracked in Medicare Part D.

Is there a generic for Cromolyn?

Yes. 9 ANDAs filed at FDA, 8 generic manufacturers currently shipping.

How much does my plan pay for Cromolyn?

Across 329 Part D plans, Cromolyn averages $0.772/unit (NADAC). Lowest available: $0.330/unit. Highest in distribution: $2.44/unit.

Is Cromolyn on the FDA shortage list?

Yes. Cromolyn is currently listed as an active FDA shortage.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (9 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.